SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036449
Filing Date
2020-08-05
Accepted
2020-08-05 08:01:15
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grts-10q_20200630.htm   iXBRL 10-Q 2971548
2 EX-10.1 grts-ex101_78.htm EX-10.1 18621
3 EX-31.1 grts-ex311_9.htm EX-31.1 20211
4 EX-31.2 grts-ex312_6.htm EX-31.2 20225
5 EX-32.1 grts-ex321_7.htm EX-32.1 13321
  Complete submission text file 0001564590-20-036449.txt   9921130

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grts-20200630.xsd EX-101.SCH 59558
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grts-20200630_cal.xml EX-101.CAL 51198
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grts-20200630_def.xml EX-101.DEF 148542
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20200630_lab.xml EX-101.LAB 429057
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20200630_pre.xml EX-101.PRE 319746
11 EXTRACTED XBRL INSTANCE DOCUMENT grts-10q_20200630_htm.xml XML 2014822
Mailing Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET, SUITE 210 EMERYVILLE CA 94608 (510) 871-6100
Gritstone Oncology, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38663 | Film No.: 201075693
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences